Virtici, LLC

OncoResponse, Inc, based in Seattle, WA, is a biotechnology company focused on discovering novel cancer immunotherapies by leveraging elite immune responses. Their mission is to attack cancer by uncovering authentic human antibodies from exceptional responders to checkpoint inhibitor therapies, with a pipeline aimed at enhancing immune activity in the tumor microenvironment. Utilizing a clinically validated Technology Platform, OncoResponse aims to develop monoclonal antibodies that target immunosuppressive myeloid biology, ultimately aiming to transform cold tumors into hot ones. Through strategic partnerships and collaborations, the company is dedicated to advancing immuno-oncology and expanding the promise of immunotherapy.Generated from the website

Icosavax, Inc. is a clinical-stage biotechnology company based in Seattle, WA, dedicated to developing innovative vaccines using their unique virus-like particle (VLP) technology. Their VLPs are designed to mimic the structure of viruses, offering potential advantages such as a stronger immune response, broader coverage against related viral strains and mutations, longer durability, and easier combinability for multiple targets in one vaccine. With a focus on protecting vulnerable older adults from respiratory viruses, Icosavax aims to revolutionize the field of vaccines by creating a new era of immunization. Their cutting-edge approach has garnered attention, leading to an agreement to be acquired by AstraZeneca and positive interim Phase 2 results for their combination VLP vaccine candidate, IVX-A12, against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in older adults.Generated from the website

Actx Inc, based in Seattle, WA, offers genomic services and personalized user experiences through their website. Users can access and use the services by accepting the terms of service, which outline legal rights and obligations. The company provides a non-exclusive license to access and use their materials, including data, software, and information, while also emphasizing the importance of privacy and feedback. Actx reserves the right to modify terms and conditions, requiring users to review and accept any changes to continue using their services.Generated from the website